ZB »

Peregrine Pharmaceuticals shares owned by ZB

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by ZB from 13F filings

Historical chart of ZB investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by ZB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by ZB

Quarter filed Position value Share count Share price at filing
2023-12-31 $431k 66k 6.50
2023-09-30 $612k 65k 9.44
2022-12-31 $5.2k 381 13.77

More positions owned by ZB

Vanguard Total Stock Market ETF (VTI)
iShares Russell Midcap Value Index (IWS)
iShares Russell Midcap Growth Idx. (IWP)
iShares S&P Natl AMTFr Mncpl Bd (MUB)
iShares Lehman Aggregate Bond (AGG)
Vanguard Dividend Appreciation ETF (VIG)
iShares S&P MidCap 400 Index (IJH)
Market Vectors Etf High Yield Muni Index etf (HYD)
Microsoft Corporation (MSFT)
Vanguard Emerging Markets ETF (VWO)
iShares Russell 2000 Value Index (IWN)
Apple (AAPL)
Amazon (AMZN)
Vanguard FTSE All-World ex-US ETF (VEU)
NVIDIA Corporation (NVDA)

View all positions for ZB

Top funds holding Peregrine Pharmaceuticals

Millennium Management
Vanguard Group
AltraVue Capital
Royal Bank of Canada
Palisade Capital Management
Wellington Management Company
Punch & Associates Investment Management
AWM Investment Company
Kornitzer Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Sargent Investment Group
Goldman Sachs Group
B. Riley Asset Management
Two Sigma Investments

View all funds holding Peregrine Pharmaceuticals